Tags: Cold/Flu | flu | vaccine | four | strains | virus | FDA

A Flu-Season First: Vaccine Against 4 Virus Strains

Tuesday, 06 Aug 2013 07:55 AM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
The U.S. Food and Drug Administration has approved shipping of the first vaccine to protect against four strains of seasonal flu.
 
The GlaxoSmithKline vaccine, called Fluarix Quadrivalent, was approved by the FDA last December for use in adults and children aged 3 and older. But approved flu vaccines still have to be certified by the FDA each season before they can be shipped to health care providers.
 
Viruses that cause seasonal flu are classified as A or B strains. Most current flu vaccines provide protection against three strains: the two A strains most common in people, and the B strain expected to be predominant in an upcoming flu season.
 
This is the first season that vaccines protecting against more than three flu strains will be available.
 
"Trivalent [three-strain] influenza vaccines offer important protection against influenza. But since the late 1980s, scientists noted that two B virus lineage strains circulate to varying degrees each year, and it's difficult to predict which one will cause the most illness in a particular influenza season. Fluarix Quadrivalent addresses this by protecting against both B strains," Dr. Leonard Friedland, vice president of scientific affairs and public policy at GlaxoSmithKline Vaccines, North America, said in a company news release.
 
The U.S. Centers for Disease Control and Prevention placed the largest order for Fluarix Quadrivalent -- more than 4 million doses -- and will distribute those doses to state and local health care providers.
 
GlaxoSmithKline estimates it will provide up to 10 million doses of quadrivalent influenza vaccine in the United States, and 22 million to 24 million doses of influenza vaccine overall. Fluarix Quadrivalent also is approved in Germany and the United Kingdom.
 
In clinical trials of the new vaccine, the most common negative side effects in adults were pain at the injection site, muscle aches, headaches and fatigue. Negative side effects among children included: pain at the injection site, redness and swelling, drowsiness, irritability, loss of appetite, fatigue, muscle aches, headache and gastrointestinal symptoms.

© HealthDay

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Are We Getting Dumber? IQ Scores Going Down

Thursday, 21 Aug 2014 16:50 PM

A new study suggests that the IQs of people in the UK, Denmark, and Australia have declined in the last decade, and that . . .

Obesity Protects Seniors From Dementia: Oxford Study

Thursday, 21 Aug 2014 16:46 PM

Obesity in old age may actually offer some protection against dementia, according to new research. The study also confir . . .

Best Depression Treatment Is Drug-Therapy Combo: Study

Thursday, 21 Aug 2014 16:38 PM

A combination of therapy and antidepressants appears to best help people with severe but short-term depression, a new st . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved